Skip to main content
Log in

Quantitative Analysis of the Rewiring of Signaling Pathways to Alter Cancer Cell Fate

  • Original Article
  • Published:
Journal of Medical and Biological Engineering Aims and scope Submit manuscript

Abstract

Purpose

Cancer occurs when signaling pathways become unregulated or constitutively activated inside a cell. For example, deregulation of the mitogen activated protein kinase (MAPK) pathway often leads to cancer by promoting uncontrolled cellular proliferation. Chimeric proteins can rewire these signal transduction pathways active in cancer cells by linking activation of the MAPK pathway to activation of the Fas apoptosis pathway, causing the input signal for cell proliferation to be redirected to induce cell death.

Methods

We present here a kinetic model demonstrating how these chimeric proteins can trigger apoptosis upon stimulation of the MAPK pathway. This model consists of ordinary differential equations using rate constants found in literature along with experimental data from previously published work. At a concentration of 1500 nM, the chimeric protein caused a 60% decrease in MAPK activation, causing the cell to transition from a proliferative state to an apoptotic state, validating previous experimental observations. Even at much lower concentrations (e.g. 24 nM), the apoptosis pathway is activated, so the model suggests that cell death may occur even without a direct suppression of the proliferation pathway.

Results and Conclusions

We have developed a quantitative model of caspase activation and its effect on the MAPK pathway in the presence of a chimeric protein, providing insight into a potential mechanism for reprogramming cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

Csp8:

Procaspase-8

Csp*:

Activated caspase-8

DED:

Death-effecter domain

EGF:

Epidermal growth factor

EGFR:

Epidermal growth factor receptor

EGFR-Csp8:

Phosphorylated EGF ligand and EGFR complex with Csp8 bound

EGFR-P:

Phosphorylated EGF ligand and EGFR complex

EGFR-PD:

Phosphorylated EGF ligand and EGFR complex with PTD-DED bound

FADD:

Fas-associated protein with death domain

LMP1:

Latent membrane protein 1

LR:

Ligand receptor complex

MAPK:

Mitogen-activated protein kinase

MOI:

Multiplicity of infection

NGF:

Nerve growth factor

PI3 K-Akt:

Phosphoinositide 3-kinase-RAC-alpha serine/threonine-protein kinase

PKC:

Protein kinase C

PMA:

Phorbol-12-myristate-13-acetate

PTB:

Phosphotyrosine binding

PTB-DED:

Chimeric protein utilizing phosphotyrosine binding (PTB) domain and death-effecter domain (DED)

RTKs:

Receptor tyrosine kinases

Shc:

Src homoloy 2 domain

TEVP:

Tobacco etch virus protease

References

  1. Dhillon, A. S., et al. (2007). MAP kinase signalling pathways in cancer. Oncogene,26(22), 3279.

    Article  Google Scholar 

  2. Blume-Jensen, P., & Hunter, T. (2001). Oncogenic kinase signalling. Nature,411(6835), 355–365.

    Article  Google Scholar 

  3. Pearson, G., et al. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews,22(2), 153–183.

    Google Scholar 

  4. Howard, P. L., et al. (2003). Redirecting tyrosine kinase signaling to an apoptotic caspase pathway through chimeric adaptor proteins. Proceedings of the National Academy of Sciences United States of America,100(20), 11267–11272.

    Article  Google Scholar 

  5. Ashkenazi, A., & Dixit, V. M. (1998). Death receptors: Signaling and modulation. Science,281(5381), 1305–1308.

    Article  Google Scholar 

  6. Brightman, F. A., & Fell, D. A. (2000). Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells. FEBS Letters,482(3), 169–174.

    Article  Google Scholar 

  7. Marshall, C. J. (1995). Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell,80(2), 179–185.

    Article  MathSciNet  Google Scholar 

  8. Kreeger, P. K., & Lauffenburger, D. A. (2010). Cancer systems biology: A network modeling perspective. Carcinogenesis,31(1), 2–8.

    Article  Google Scholar 

  9. Anderson, A. R., et al. (2006). Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell,127(5), 905–915.

    Article  Google Scholar 

  10. Haeno, H., et al. (2009). A progenitor cell origin of myeloid malignancies. Proceedings of the National Academy of Sciences United States of America,106(39), 16616–16621.

    Article  Google Scholar 

  11. Altrock, P. M., Liu, L. L., & Michor, F. (2015). The mathematics of cancer: integrating quantitative models. Nature Reviews Cancer,15(12), 730.

    Article  Google Scholar 

  12. Willerth, S. M., & Sakiyama-Elbert, S. E. (2009). Kinetic analysis of neurotrophin-3-mediated differentiation of embryonic stem cells into neurons. Tissue Engineering Part A,15(2), 307–318.

    Article  Google Scholar 

  13. Aksan, I., & Kurnaz, M. L. (2003). A computer-based model for the regulation of mitogen activated protein kinase (MAPK) activation. Journal of Receptor and Signal Transduction Research,23(2–3), 197–209.

    Article  Google Scholar 

  14. Maly, I. V., Wiley, H. S., & Lauffenburger, D. A. (2004). Self-organization of polarized cell signaling via autocrine circuits: Computational model analysis. Biophysical Journal,86(1 Pt 1), 10–22.

    Article  Google Scholar 

  15. Kholodenko, B. N., et al. (1999). Quantification of short term signaling by the epidermal growth factor receptor. Journal of Biological Chemistry,274(42), 30169–30181.

    Article  Google Scholar 

  16. Yamada, S., Taketomi, T., & Yoshimura, A. (2004). Model analysis of difference between EGF pathway and FGF pathway. Biochemical and Biophysical Research Communications,314(4), 1113–1120.

    Article  Google Scholar 

  17. Chen, W. W., et al. (2009). Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data. Mol Syst Biol,5, 239.

    Article  Google Scholar 

  18. Neumann, L., et al. (2010). Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Molecular Systems Biology,6, 352.

    Article  Google Scholar 

  19. Bentele, M., et al. (2004). Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis. Journal of Cell Biology,166(6), 839–851.

    Article  Google Scholar 

  20. Hua, F., et al. (2005). Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: molecular genetic tests of computational model predictions. Journal of Immunology,175(2), 985–995.

    Article  MathSciNet  Google Scholar 

  21. Lauffenburger, D. A., & Linderman, J. J. (1993). Receptors: Models for binding, trafficking, and signalling (p. 361). New York: Oxford University Press.

    Google Scholar 

  22. Li, S. C., et al. (1996). Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein. Journal of Biological Chemistry,271(50), 31855–31862.

    Article  Google Scholar 

  23. He, Y. Y., Huang, J. L., & Chignell, C. F. (2006). Cleavage of epidermal growth factor receptor by caspase during apoptosis is independent of its internalization. Oncogene,25(10), 1521–1531.

    Article  Google Scholar 

  24. Bae, S. S., et al. (2001). Proteolytic cleavage of epidermal growth factor receptor by caspases. FEBS Letters,491(1–2), 16–20.

    Article  Google Scholar 

  25. Pritalas, C. A., & Solit, D. B. (2010). Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response. Clinical Cancer Research,16(13), 3329–3334.

    Article  Google Scholar 

  26. Gao, Q., et al. (2018). Driver fusions and their implications in the development and treatment of human cancers. Cell Reports,23, 227–238.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank to Dr. Satoshi Yamada and colleagues for supplying us with the equations and parameters for their model as well as Dr. Perry Howard for many helpful conversations, insights and direction. This work was supported by an NSERC URSA award (RS), NSERC Discovery Grants (RE and SMW), and the Canada Research Chairs program (SMW).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephanie M. Willerth.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Electronic supplementary material 1 (DOCX 34 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmitz, R.M., Willerth, S.M., van Rensburg, G. et al. Quantitative Analysis of the Rewiring of Signaling Pathways to Alter Cancer Cell Fate. J. Med. Biol. Eng. 40, 41–52 (2020). https://doi.org/10.1007/s40846-019-00489-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40846-019-00489-4

Keywords

Navigation